Questar Corp (STR) 25.04 $STR Questar Shares Up 26.9%

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Questar Corp (STR) 25.04 $STR

Questar Shares Up 26.9% Since SmarTrend's Buy Recommendation (STR)
Comtex SmarTrend(R) - Tue Sep 06, 1:56PM CDT
SmarTrend identified an Uptrend for Questar (NYSE:STR) on December 24th, 2015 at $19.74. In approximately 9 months, Questar has returned 26.93% as of today's recent price of $25.06.
STR: 25.04 (-0.03)

Uptrend Call Working As Questar Stock Rises 26.5% (STR)
Comtex SmarTrend(R) - Fri Aug 26, 1:24PM CDT
SmarTrend identified an Uptrend for Questar (NYSE:STR) on December 24th, 2015 at $19.74. In approximately 8 months, Questar has returned 26.55% as of today's recent price of $24.98.
STR: 25.04 (-0.03)

Questar's Merger with Dominion Okayed by Utah Regulators
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 8:44AM CDT
Natural gas-focused energy company Questar Corp.'s (STR) proposed purchase by Virginia-based Dominion Resources, Inc. (D) received nod from Public Service Commission of Utah, subject to certain terms and conditions.
D: 75.50 (+0.75), STR: 25.04 (-0.03), NWN: 60.43 (unch), JE: 5.64 (+0.09)

Dominion-Questar Merger Moves Closer After Approval From Utah's Public Service Commission
PR Newswire - Tue Aug 23, 7:00AM CDT
Dominion Resources, Inc. (NYSE: D) and Questar Corporation (NYSE: STR) announced today that the Public Service Commission of Utah has approved their merger, subject to terms and conditions of an agreed settlement stipulation, thereby moving the proposed combination one step closer to finalization. With the PSC of Utah's action, the final regulatory approval needed to complete the merger is pending with the Wyoming Public Service Commission.
D: 75.50 (+0.75), STR: 25.04 (-0.03)

Questar Up 28.0% Since SmarTrend Uptrend Call (STR)
Comtex SmarTrend(R) - Thu Aug 11, 1:22PM CDT
SmarTrend identified an Uptrend for Questar (NYSE:STR) on December 24th, 2015 at $19.74. In approximately 8 months, Questar has returned 27.96% as of today's recent price of $25.26.
STR: 25.04 (-0.03)

Dominion Announces Pricing of Equity Units
PR Newswire - Wed Aug 10, 7:30AM CDT
Dominion (NYSE: D) announced today that it has priced its offering of 25 million 2016 Series A equity units. Each 2016 Series A equity unit will be issued in a stated amount of $50 ($1.25 billion aggregate stated amount) and will consist of a contract to purchase common stock in the future, a 1/40 undivided beneficial ownership interest in Dominion's 2016 Series A-1 remarketable subordinated notes due 2021 having a principal amount of $1,000 and a 1/40 undivided beneficial ownership interest in Dominion's 2016 Series A-2 remarketable subordinated notes due 2024 having a principal amount of $1,000. Each of the remarketable subordinated notes is subject to remarketing to commence no earlier than May 13, 2019. The offering is expected to close on Aug. 15, 2016, subject to customary closing conditions.
D: 75.50 (+0.75), STR: 25.04 (-0.03)

Questar (STR) Misses Q2 Earnings and Revenue Estimates
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 9:37AM CDT
Natural gas-focused energy company, Questar Corp. (STR), reported adjusted second-quarter earnings of 20 cents per share that missed the Zacks Consensus Estimate of 22 cents.
D: 75.50 (+0.75), STR: 25.04 (-0.03), CPK: 63.40 (-0.37), JE: 5.64 (+0.09)

Dominion Announces Equity Units Offering
PR Newswire - Mon Aug 08, 3:01PM CDT
Dominion (NYSE: D) announced today its intention to offer to sell 25 million equity units, subject to market and other conditions. Each equity unit will be issued in a stated amount of $50 and will consist of a contract to purchase common stock in the future and two 1/40 undivided beneficial ownership interests in remarketable subordinated notes each having a principal amount of $1,000. Dominion expects to grant to the underwriters an option to purchase an additional 3 million equity units to cover over-allotments.
D: 75.50 (+0.75), STR: 25.04 (-0.03)

Fitch Rates Dominion Resources Senior Notes 'BBB+'
BusinessWire - Thu Aug 04, 4:55PM CDT
Fitch Ratings has assigned a 'BBB+' rating to Dominion Resources, Inc.'s (DRI) multiple tranche offering of $500 million 2016 series B 1.60% senior notes due 2019, $400 million 2016 series C 2.00% senior notes due 2021 and $400 million 2016 series D 2.85% senior notes due 2026. The Rating Outlook is Stable.
D: 75.50 (+0.75), STR: 25.04 (-0.03)

Shares of STR Up 27.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Aug 04, 12:58AM CDT
SmarTrend identified an Uptrend for Questar (NYSE:STR) on December 24th, 2015 at $19.74. In approximately 7 months, Questar has returned 27.61% as of today's recent price of $25.19.
STR: 25.04 (-0.03)

Questar Reports Second-Quarter 2016 Adjusted Earnings of $35.4 Million, $0.20 Per Diluted Share
BusinessWire - Wed Aug 03, 3:55PM CDT
Questar Corporation (NYSE:STR) reported second-quarter 2016 net income of $33.1 million, or $0.19 per diluted share. This included $2.3 million of after-tax merger and restructuring costs. Excluding these costs, adjusted earnings were $35.4 million, or $0.20 per adjusted diluted share, compared to second-quarter 2015 net income of $40.6 million, or $0.23 per diluted share. Adjusted earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) for the quarter were $126.5 million compared to $130.1 million in the year-ago period. Return on average common equity (ROE) was 14.6% for the 12 months ended June 30, 2016. When calculated using adjusted earnings, Questar's ROE was 16.6%.
STR: 25.04 (-0.03)

Questar Board Declares 287th Consecutive Dividend
BusinessWire - Mon Aug 01, 7:17PM CDT
Questar Corp.'s (NYSE:STR) board of directors today approved a $0.22 (22 cents) quarterly common stock cash dividend. The dividend, payable September 12, 2016, to shareholders of record on August 19, 2016, is the same as the previous quarter. This is the company's 287th consecutive dividend.
D: 75.50 (+0.75), STR: 25.04 (-0.03)

Questar Has Returned 26.7% Since SmarTrend Recommendation (STR)
Comtex SmarTrend(R) - Fri Jun 17, 12:53AM CDT
SmarTrend identified an Uptrend for Questar (NYSE:STR) on December 24th, 2015 at $19.74. In approximately 6 months, Questar has returned 26.75% as of today's recent price of $25.02.
STR: 25.04 (-0.03)

If You Seek a Stable Portfolio, Utilities Are a Must
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 3:01PM CDT
If You Seek a Stable Portfolio, Utilities Are a Must
D: 75.50 (+0.75), STR: 25.04 (-0.03), GXP: 27.90 (+0.30), WTR: 31.11 (+0.13), WR: 55.28 (+0.03), DUK: 81.06 (+0.12), EXC: 34.45 (+0.38), AWK: 75.90 (+1.10), CNP: 22.80 (+0.17), CTWS: 46.73 (+0.33)

Premarket Research Report Covering the Gas Utilities' Industry
ACCESSWIRE - Fri Jun 10, 8:16AM CDT
LONDON, UK / ACCESSWIRE / June 10, 2016 / ActiveWallSt.com announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Gas Utilities industry. Companies recently under review include Clean Energy Fuels, Questar, Southcross Energy Partners, and AGL Resources. Register with us now for your free membership and see our complete reports on these equities at: http://www.activewallst.com/register/.
STR: 25.04 (-0.03), GAS: 65.97 (-0.02), SXE: 1.69 (-0.03), CLNE: 4.64 (+0.07)

26.8% Return Seen to Date on SmarTrend Questar Call (STR)
Comtex SmarTrend(R) - Thu Jun 02, 12:56AM CDT
SmarTrend identified an Uptrend for Questar (NYSE:STR) on December 24th, 2015 at $19.74. In approximately 5 months, Questar has returned 26.80% as of today's recent price of $25.03.
STR: 25.04 (-0.03)

Great Plains Energy (GXP) to Acquire Westar for $12.2 Billion
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 6:48AM CDT
Great Plains Energy Inc. (GXP) announced that it has entered into an agreement to acquire Westar Energy Inc. (WR).
D: 75.50 (+0.75), STR: 25.04 (-0.03), GXP: 27.90 (+0.30), WR: 55.28 (+0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading